Fig. 1.
Fig. 1. Cumulative incidence of grade II-IV acute GVHD of 165 patients who received cyclosporine/methotrexate, 44.4% (◊) and 164 patients who received tacrolimus/methotrexate, 31.9% (□); absolute difference = 12.5%, 95% CI = −23.9 to −1.2 (P = .01, Wilcoxon).

Cumulative incidence of grade II-IV acute GVHD of 165 patients who received cyclosporine/methotrexate, 44.4% (◊) and 164 patients who received tacrolimus/methotrexate, 31.9% (□); absolute difference = 12.5%, 95% CI = −23.9 to −1.2 (P = .01, Wilcoxon).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal